The global microfluidics market is expected to witness high growth, exhibiting a CAGR of 13.0% over the forecast period of 2023-2030. This growth can be attributed to the increasing demand for point-of-care diagnostics and personalized medicine, as well as the expanding applications of microfluidics technology in drug discovery and development.
In terms of regional analysis, North America is expected to be the fastest growing and dominating region in the microfluidics market. This can be attributed to the presence of key players in the region, technological advancements, and the increasing adoption of microfluidic devices in various sectors.
Key players operating in the microfluidics market include Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Abbott Laboratories, and F. Hoffmann-La Roche Ltd. These companies have established a strong presence in the market and are actively involved in research and development activities to enhance their product offerings and maintain a competitive edge.
Read More:
